MOH — authorised 12 August 2020
- Marketing authorisation holder: NIPPON SHINYAKU
- Status: likely_approved
MOH authorised Viltepso on 12 August 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 12 August 2020.
NIPPON SHINYAKU holds the UAE marketing authorisation.